+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Steroid Injections Market - Global Forecast 2026-2032- Product Image
Steroid Injections Market - Global Forecast 2026-2032- Product Image
New

Steroid Injections Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012190
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Steroid injections play a vital role in modern healthcare, bridging established pharmacology and evolving clinical practice to drive targeted care delivery in musculoskeletal and inflammatory conditions. Stakeholders need strategic clarity to navigate clinical, operational, and regulatory changes shaping this essential market.

Market Snapshot

The Steroid Injections Market grew from USD 5.72 billion in 2025 to USD 6.20 billion in 2026. The market is anticipated to progress at a CAGR of 8.90%, reaching USD 10.39 billion by 2032.

Steroid Injections Market Scope & Segmentation

This report delivers an in-depth analysis across the following dimensions, enabling leaders to align strategies with evolving market demands:

  • Molecule Types: Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone—each offering unique potency, solubility, and duration characteristics to match clinician and patient requirements.
  • Treatment Pathways: Joint injections (large and small joints), soft tissue injections (bursa, ligament, tendon), and spinal injections (epidural, intrathecal); each procedure involves specific protocols and device needs.
  • Patient Cohorts: Adult, geriatric, and pediatric groups, highlighting distinctive safety, consent, and aftercare priorities.
  • Therapeutic Indications: Back pain (including subtypes), osteoarthritis, rheumatoid arthritis, bursitis, and tendonitis, with clinical guidelines shaping care pathways.
  • End User Environments: Ambulatory surgical centers, clinics, and hospitals—including general and specialty categories—impact procurement, compounding, and formulary strategies.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies (split by chain and independent models), with implications for access and dispensing workflows.
  • Regional Coverage: Americas, Europe Middle East Africa, and Asia Pacific, each defined by regulatory expectations, insurance structures, infrastructure, and local adoption patterns.
  • Technological Innovations: Advances in formulation, delivery systems, and health IT are transforming administration, tracking, and real-world outcome measurement.

Key Takeaways for Stakeholders

  • Integrated clinical, supply chain, and commercial perspectives are essential for anticipating shifts in demand and aligning investments with payer and patient expectations.
  • Outpatient and ambulatory migration is accelerating, requiring efficient supply logistics and tailored procurement strategies that match procedural practice patterns.
  • Rising evidence and safety requirements from payers and procurement teams are driving manufacturers to enhance post-market surveillance and build pragmatic clinical datasets.
  • Operational flexibility, including supplier diversification and regionalized production, mitigates trade policy disruptions and reinforces continuity for healthcare providers.
  • Segmented marketing and education—differentiated by molecule, procedure, and care setting—enable more precise engagement and improved clinical adoption.
  • Successful organizations integrate data-driven decision-making, leveraging practice guidelines and reimbursement models to navigate regional variability and maximize coverage.

Tariff Impact on the Steroid Injections Market

United States tariff measures enacted in 2025 have increased complexity across supply chains and procurement. Import duties on pharmaceutical intermediates and components have raised landed costs, causing procurement strategies to shift focus toward supplier diversification and inventory buffering. These policies have driven local sourcing, more robust contract management, and heightened attention to administrative compliance for manufacturers and healthcare institutions. Over time, supply chain resilience and strategic contracting have become essential, with industry participants favoring long-term, transparent supplier relationships to manage cost and continuity in a variable trade environment.

Methodology & Data Sources

This report utilizes a mixed-methods approach: a targeted review of clinical literature and guidelines, in-depth analysis of procurement data and hospital formularies, and structured interviews with clinicians, procurement leaders, and supply chain managers. Findings are synthesized using triangulation and segmentation mapping to ensure actionable, validated insight for decision-makers.

Why This Steroid Injections Market Report Matters

  • Enables senior leaders to anticipate operational, clinical, and regulatory trends with a clear, data-backed roadmap for portfolio alignment.
  • Supports investment prioritization and risk mitigation by linking evidence generation, supply strategy, and market access levers.
  • Equips stakeholders with regionally relevant insights on care patterns, procurement behavior, and evolving clinical guidelines for immediate strategic advantage.

Conclusion

Senior stakeholders navigating the steroid injections market must align clinical, operational, and commercialization strategies with emerging trends in care delivery and regulation. This report offers a practical, segment-informed framework for sustainable growth and informed decision-making.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Steroid Injections Market, by Molecule Type
8.1. Dexamethasone
8.2. Hydrocortisone
8.3. Methylprednisolone
8.4. Triamcinolone
9. Steroid Injections Market, by Treatment Type
9.1. Joint Injections
9.1.1. Large Joints
9.1.2. Small Joints
9.2. Soft Tissue Injections
9.2.1. Bursa Injections
9.2.2. Ligament Injections
9.2.3. Tendon Injections
9.3. Spinal Injections
9.3.1. Epidural
9.3.2. Intrathecal
10. Steroid Injections Market, by Patient Type
10.1. Adult
10.2. Geriatric
10.3. Pediatric
11. Steroid Injections Market, by Therapeutic Indication
11.1. Back Pain
11.1.1. Lower Back Pain
11.1.2. Sciatica
11.1.3. Upper Back Pain
11.2. Bursitis
11.3. Osteoarthritis
11.4. Rheumatoid Arthritis
11.5. Tendonitis
12. Steroid Injections Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Clinics
12.3. Hospitals
12.3.1. General Hospitals
12.3.2. Specialty Hospitals
13. Steroid Injections Market, by Distribution Channel
13.1. Hospital Pharmacies
13.2. Online Pharmacies
13.3. Retail Pharmacies
13.3.1. Chain Pharmacies
13.3.2. Independent Pharmacies
14. Steroid Injections Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Steroid Injections Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Steroid Injections Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Steroid Injections Market
18. China Steroid Injections Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. AbbVie Inc.
19.6. Bayer AG
19.7. Bristol-Myers Squibb Company
19.8. Johnson & Johnson
19.9. Merck & Co., Inc.
19.10. Novartis AG
19.11. Pfizer Inc.
19.12. Roche Holding AG
19.13. Teva Pharmaceutical Industries Ltd.
19.14. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL STEROID INJECTIONS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL STEROID INJECTIONS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES STEROID INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA STEROID INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL STEROID INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DEXAMETHASONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DEXAMETHASONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DEXAMETHASONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HYDROCORTISONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL STEROID INJECTIONS MARKET SIZE, BY METHYLPREDNISOLONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TRIAMCINOLONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LARGE JOINTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SMALL JOINTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSA INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSA INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSA INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LIGAMENT INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LIGAMENT INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LIGAMENT INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDON INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDON INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDON INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL STEROID INJECTIONS MARKET SIZE, BY EPIDURAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRATHECAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRATHECAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INTRATHECAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADULT, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADULT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL STEROID INJECTIONS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LOWER BACK PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LOWER BACK PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL STEROID INJECTIONS MARKET SIZE, BY LOWER BACK PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SCIATICA, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SCIATICA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SCIATICA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL STEROID INJECTIONS MARKET SIZE, BY UPPER BACK PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL STEROID INJECTIONS MARKET SIZE, BY UPPER BACK PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL STEROID INJECTIONS MARKET SIZE, BY UPPER BACK PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL STEROID INJECTIONS MARKET SIZE, BY BURSITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL STEROID INJECTIONS MARKET SIZE, BY OSTEOARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDONITIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDONITIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL STEROID INJECTIONS MARKET SIZE, BY TENDONITIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL STEROID INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL STEROID INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL STEROID INJECTIONS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GENERAL HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GENERAL HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GENERAL HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL STEROID INJECTIONS MARKET SIZE, BY SPECIALTY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL STEROID INJECTIONS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL STEROID INJECTIONS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CHAIN PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL STEROID INJECTIONS MARKET SIZE, BY CHAIN PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL STEROID INJECTIONS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL STEROID INJECTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 120. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 121. AMERICAS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 122. AMERICAS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 123. AMERICAS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 124. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 125. AMERICAS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 126. AMERICAS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 127. AMERICAS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 128. AMERICAS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 129. AMERICAS STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 130. AMERICAS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 131. AMERICAS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 132. AMERICAS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 133. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 135. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 136. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 137. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 138. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 139. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 140. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 141. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 142. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 144. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 145. NORTH AMERICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 146. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 148. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 149. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 150. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 151. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 152. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 153. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 154. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 155. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 156. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 157. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 158. LATIN AMERICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 172. EUROPE STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. EUROPE STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 174. EUROPE STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 175. EUROPE STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 176. EUROPE STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 177. EUROPE STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 178. EUROPE STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 179. EUROPE STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 180. EUROPE STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 181. EUROPE STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. EUROPE STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 183. EUROPE STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 184. EUROPE STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 185. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 186. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 187. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 188. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 189. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 190. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 191. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 192. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 193. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 194. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 195. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 196. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. MIDDLE EAST STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 198. AFRICA STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. AFRICA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 200. AFRICA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 201. AFRICA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 202. AFRICA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 203. AFRICA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 204. AFRICA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 205. AFRICA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 206. AFRICA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 207. AFRICA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. AFRICA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 209. AFRICA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. AFRICA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 211. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 213. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 214. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 215. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 216. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 217. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 218. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 219. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 220. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 221. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 222. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 223. ASIA-PACIFIC STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL STEROID INJECTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 225. ASEAN STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. ASEAN STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 227. ASEAN STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 228. ASEAN STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 229. ASEAN STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 230. ASEAN STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 231. ASEAN STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 232. ASEAN STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 233. ASEAN STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 234. ASEAN STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 235. ASEAN STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 236. ASEAN STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 237. ASEAN STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 238. GCC STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 239. GCC STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 240. GCC STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 241. GCC STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 242. GCC STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 243. GCC STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 244. GCC STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 245. GCC STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 246. GCC STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 247. GCC STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 248. GCC STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 249. GCC STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 250. GCC STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 251. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 252. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 253. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 254. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 264. BRICS STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 265. BRICS STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 266. BRICS STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 267. BRICS STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 268. BRICS STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 269. BRICS STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 270. BRICS STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 271. BRICS STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 272. BRICS STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 273. BRICS STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 274. BRICS STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 275. BRICS STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 276. BRICS STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 277. G7 STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 278. G7 STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 279. G7 STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 280. G7 STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 281. G7 STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 282. G7 STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 283. G7 STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 284. G7 STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 285. G7 STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 286. G7 STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 287. G7 STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 288. G7 STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 289. G7 STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 290. NATO STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 291. NATO STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 292. NATO STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 293. NATO STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 294. NATO STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 295. NATO STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 296. NATO STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 297. NATO STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 298. NATO STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 299. NATO STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 300. NATO STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 301. NATO STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 302. NATO STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 303. GLOBAL STEROID INJECTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 304. UNITED STATES STEROID INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 305. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 306. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 307. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 308. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 309. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 310. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 311. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 312. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 313. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 314. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 315. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 316. UNITED STATES STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)
TABLE 317. CHINA STEROID INJECTIONS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 318. CHINA STEROID INJECTIONS MARKET SIZE, BY MOLECULE TYPE, 2018-2032 (USD MILLION)
TABLE 319. CHINA STEROID INJECTIONS MARKET SIZE, BY TREATMENT TYPE, 2018-2032 (USD MILLION)
TABLE 320. CHINA STEROID INJECTIONS MARKET SIZE, BY JOINT INJECTIONS, 2018-2032 (USD MILLION)
TABLE 321. CHINA STEROID INJECTIONS MARKET SIZE, BY SOFT TISSUE INJECTIONS, 2018-2032 (USD MILLION)
TABLE 322. CHINA STEROID INJECTIONS MARKET SIZE, BY SPINAL INJECTIONS, 2018-2032 (USD MILLION)
TABLE 323. CHINA STEROID INJECTIONS MARKET SIZE, BY PATIENT TYPE, 2018-2032 (USD MILLION)
TABLE 324. CHINA STEROID INJECTIONS MARKET SIZE, BY THERAPEUTIC INDICATION, 2018-2032 (USD MILLION)
TABLE 325. CHINA STEROID INJECTIONS MARKET SIZE, BY BACK PAIN, 2018-2032 (USD MILLION)
TABLE 326. CHINA STEROID INJECTIONS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 327. CHINA STEROID INJECTIONS MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 328. CHINA STEROID INJECTIONS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 329. CHINA STEROID INJECTIONS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Steroid Injections market report include:
  • AbbVie Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Roche Holding AG
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 6.2 Billion
Forecasted Market Value ( USD ) by 2032 $ 10.39 Billion
Compound Annual Growth Rate8.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Joint Pain Injections Market Report 2025 - Product Image

Joint Pain Injections Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Image

Joint Pain Injections Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • 181 Pages
  • Global
From
Joint Pain Injections Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Joint Pain Injections Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Injection-grade Plant Derived Cholesterol Market - Global Forecast 2025-2030 - Product Image

Injection-grade Plant Derived Cholesterol Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Facet-Joint Injection Global Market Report 2025 - Product Image

Facet-Joint Injection Global Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Steroid Injections Market

The steroid injections market is a subset of the broader infusions and injectables sector, focusing on products that deliver steroids directly into the body tissues, including joints, muscles, and the spine. Steroids, which are synthetic drugs that closely resemble cortisol, a hormone that the body produces naturally, are used to reduce inflammation and suppress the immune system. They are commonly prescribed for a range of conditions including arthritis, back pain, and various inflammatory diseases. The market comprises a variety of steroid types, including cortisone, methylprednisolone, and triamcinolone, among others. These injections are often administered in outpatient settings like clinics and hospitals by healthcare professionals, including doctors and nurses, who are skilled in performing these procedures. The sector is influenced by factors such as the prevalence of chronic diseases, advancements in drug formulations, and improvements in administration techniques, providing patients with pain management and symptomatic relief options. Some notable players in the steroid injections market include Pfizer Inc., Novartis AG, Merck & Co., Inc., Johnson & Johnson, and Bristol-Myers Squibb Company. These companies are engaged in the production and distribution of steroid injectables and continuously invest in research and development to improve the efficacy and safety profiles of their products. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.